Stock listing

Lee's Pharmaceutical Holdings Limited

Selected listing: A12CU5 · LS · EUR · DE

Lee's Pharmaceutical Holdings Limited (Lang & Schwarz: A12CU5), Health Technology. Latest release Oct 2, 2026: Monthly Return of Equity Issuer on Movements…

A12CU5:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A12CU5
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

About Lee's Pharmaceutical Holdings Limited

The company focuses on the development and commercialization of pharmaceutical products. Lee's Pharmaceutical aims to enhance healthcare solutions through innovative therapies and strategic partnerships.

Latest news from Lee's Pharmaceutical Holdings Limited

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026

October 2, 2026

Lee Pharmaceutical : Connected Transaction - Provision of Financial Assistance

April 28, 2021

Lee Pharmaceutical : Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed from Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China

February 10, 2021

Lee's Pharmaceutical Holdings Limited : - Grant of Share Options

October 26, 2020

Lee's Pharmaceutical Holdings Limited : - Establishment of the Group Commercial Operations Centre

October 26, 2020

All Lee's Pharmaceutical Holdings Limited news →

Research Lee's Pharmaceutical Holdings Limited

Lee's Pharmaceutical Holdings Limited company profile

View the public company page for Lee's Pharmaceutical Holdings Limited on 6ix.

Lee's Pharmaceutical Holdings Limited news

Read company news and market updates connected to Lee's Pharmaceutical Holdings Limited.

Lee's Pharmaceutical Holdings Limited investor events

Find investor webinars, events, and replay context for Lee's Pharmaceutical Holdings Limited.